| Ruthenium-Catalyzed Azide-Alkyne Cycloaddition: Scope and Mechanism (vol 130, pg 8923, 2008) BC Boren, S Narayan, LK Rasmussen, L Zhang, HT Zhao, ZY Lin, GC Jia, ... Journal of the American Chemical Society 130 (44), 14900-14900, 2008 | 1128* | 2008 |
| Ruthenium-catalyzed azide− alkyne cycloaddition: Scope and mechanism BC Boren, S Narayan, LK Rasmussen, L Zhang, H Zhao, Z Lin, G Jia, ... Journal of the American Chemical Society 130 (28), 8923-8930, 2008 | 1118 | 2008 |
| Ruthenium-catalyzed cycloaddition of aryl azides and alkynes LK Rasmussen, BC Boren, VV Fokin Organic Letters 9 (26), 5337-5339, 2007 | 415 | 2007 |
| Triazolopyrazinones as PDE1 inhibitors J Kehler, LK Rasmussen, M Jessing US Patent App. 10/150,771, 2018 | 66* | 2018 |
| Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET A Ettrup, M Palner, N Gillings, MA Santini, M Hansen, BR Kornum, ... Journal of Nuclear Medicine 51 (11), 1763-1770, 2010 | 59 | 2010 |
| Facile Synthesis of mono-, di-, and trisubstituted alpha-unbranched hydrazines LK Rasmussen The Journal of organic chemistry 71 (9), 3627-3629, 2006 | 45 | 2006 |
| Resin-bound triaryl bismuthanes and bismuth diacetates: Novel multidirectional linkers and novel resin-bound arylation reagents LK Rasmussen, M Begtrup, T Ruhland The Journal of organic chemistry 69 (20), 6890-6893, 2004 | 35 | 2004 |
| Halogenated quinazolin-THF-amines as PDE1 inhibitors J Kehler, LK Rasmussen, M Langgård US Patent App. 10/005,764, 2018 | 28* | 2018 |
| Solid-phase synthesis with resin-bound triarylbismuthanes: Traceless and multidirectional cleavage of unsymmetrical biphenyls LK Rasmussen, M Begtrup, T Ruhland The Journal of organic chemistry 71 (3), 1230-1232, 2006 | 24 | 2006 |
| Imidazopyrazinones as PDE1 inhibitors J Kehler, LK Rasmussen, M Langgård, M Jessing US Patent 10,011,606, 2018 | 23* | 2018 |
| PDE1A inhibition elicits cGMP‐dependent relaxation of rat mesenteric arteries MM Khammy, T Dalsgaard, PH Larsen, CT Christoffersen, D Clausen, ... British journal of pharmacology 174 (22), 4186-4198, 2017 | 22 | 2017 |
| Benzamides-containing compounds and their use in the treatment of epilepsy JP Kilburn, LK Rasmussen, M Jessing, EM Eldemenky, B Chen, Y Jiang, ... US Patent 10,238,654, 2019 | 21* | 2019 |
| Characterisation of Lu AF33241: A novel, brain-penetrant, dual inhibitor of phosphodiesterase (PDE) 2A and PDE10A JP Redrobe, LK Rasmussen, CT Christoffersen, C Bundgaard, ... European journal of pharmacology 761, 79-85, 2015 | 19 | 2015 |
| 1H-Pyrazolo [4, 3-b] pyridines as PDE1 Inhibitors J Kehler, K Juhl, M Marigo, PJV Vital, M Jessing, M Langgård, ... US Patent App. 15/637,920, 2018 | 14 | 2018 |
| Ruthenium-catalysed isomerisation of allylhydrazines: A new entry to the fischer indole synthesis SD Nielsen, T Ruhland, LK Rasmussen Synlett 2007 (03), 0443-0446, 2007 | 12 | 2007 |
| Pyrazolo [3, 4-b] pyridines and imidazo [1, 5-b] pyridazines as PDE1 inhibitors J Kehler, LK Rasmussen, M Langgard, M Jessing, PJV Vital, K Juhl, ... US Patent 10,351,561, 2019 | 11 | 2019 |
| Cyclic amines JP Kilburn, LK Rasmussen, M Jessing, EM Eldemenky, B Chen, Y Jiang US Patent 10,124,010, 2018 | 11* | 2018 |
| Imidazotriazinones as PDE1 Inhibitors J Kehler, LK Rasmussen, M Langgård, M Jessing, PJV Vital, K Juhl US Patent App. 15/133,715, 2016 | 11 | 2016 |
| 1h-pyrazolo [4, 3-b] pyridines as pde1 inhibitors K Juhl, M Jessing, M Langgård, PJV Vital, J Kehler, LK Rasmussen, ... US Patent App. 16/218,019, 2019 | 10 | 2019 |
| Macrocycles as pde1 inhibitors K Juhl, M Jessing, M Langgård, PJV Vital, J Kehler, LK Rasmussen, ... US Patent App. 16/217,754, 2019 | 10 | 2019 |
